Sorafenib in Hormone Naïve Biochemical Recurrence of Prostate Cancer

Summary

The purpose of this study is to measure the benefit of sorafenib in patients with a rising PSA after treatment with radiation therapy or surgery who are NOT receiving with androgen ablation therapy.

Timeline

Start

2008-06

Primary completion

2010-06

Completion

—

Drugs

Indications